Wiadomości

AI-Based Clinical Trial Solutions for Patient Matching - Global Strategic Business Report 2026: Capitalize on 25% CAGR and $3.4B in Total Revenue by 2032 with Medidata, Microsoft, ConcertAI and Unlearn.ai

Yahoo

Company Logo Dublin, Nov. 18, 2026 (GLOBE NEWSWIRE) -- "AI-based Clinical Trial Solutions for Patient Matching - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global artificial intelligence-based clinical trial solutions for patient matching market was valued at US$721.6 million in 2025 and is projected to reach US$3.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 25% during the forecast period. Market growth is being supported by increasing clinical trial complexity, demand for precision medicine, rising research and development costs, and the need to improve patient recruitment efficiency.

Przeczytaj pelny brief Veytics

Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.